Eli Lilly and Merck’s blockbuster drug sales power earnings ⊕⊕
found
a story from Financial Times ✅ › Financial Times
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2025 › October › 30
Merck
8 months ago
Pharma groups boost financial outlooks as revenues from flagship medicines like Zepbound and Keytruda leap
Stocks making the biggest moves premarket: Alphabet, Microsoft, Meta Platforms, Eli Lilly, Merck & more ○
These are some of the stocks posting the largest moves in early trading.
Merck tops estimates on Keytruda strength and narrows profit outlook, as it lowers estimated tariff hit ⊕⊕
Merck said its narrowed profit guidance reflects several new items, including "lower estimated costs related to the impact of tariffs."
page 1 of 1